SAN FRANCISCO, CA – (March 20, 2025) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in enCore Energy Corp. (“enCore” or the “Company”) (NASDAQ: EU) who purchased or otherwise acquired enCore securities between March 28, 2024 and March 2, 2025, inclusive (the “Class Period”) to contact us immediately regarding a
SAN FRANCISCO, CA – (March 5, 2025) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in Atkore Inc. (“Atkore” or the “Company”) (NYSE: ATKR) who purchased Atkore common stock between February 1, 2024, and February 3, 2025, inclusive (the “Class Period”) to contact us immediately regarding a pending securities class
SAN FRANCISCO, CA – (February 6, 2025) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in Novo Nordisk A/S. (“Novo” or the “Company”) (NYSE: NVO) who purchased or otherwise acquired Novo securities between November 2, 2022, and December 19, 2024, inclusive (the “Class Period”) to contact us immediately regarding a
SAN FRANCISCO, CA – (December 21, 2023) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in National Instruments Corporation (“National Instruments” or “NATI” or the “Company”) (NASDAQ: NATI) who suffered losses from selling NATI common stock between May 25, 2022 and January 17, 2023 to contact us immediately regarding a
SAN FRANCISCO, CA – (December 14, 2023) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in Dollar General Corporation (“Dollar General” or the “Company”) (NYSE: DG) who suffered losses from purchasing or otherwise acquiring the securities of Dollar General between May 28, 2020 and August 31, 2023 to contact us
SAN FRANCISCO, CA – (December 11, 2023) – National plaintiffs’ law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in FMC Corporation (“FMC” or the “Company”) (NYSE: FMC) who suffered losses from purchasing or otherwise acquiring FMC common stock between February 9, 2022 and October 30, 2023 to contact us immediately regarding a pending
SAN FRANCISCO, CA – (November 9, 2023) – National plaintiffs law firm Lieff Cabraser Heimann & Bernstein, LLP encourages investors in DocGo Inc. (“DocGo” or the “Company”) (Nasdaq: DCGO) who suffered losses from purchasing or otherwise acquiring the securities of DocGo between November 8, 2022 and September 17, 2023 to contact us immediately regarding a